Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (3,417) Arrow Down
Filter Results: (3,417) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (3,417)
    • People  (9)
    • News  (720)
    • Research  (2,192)
    • Events  (38)
    • Multimedia  (28)
  • Faculty Publications  (1,297)

Show Results For

  • All HBS Web  (3,417)
    • People  (9)
    • News  (720)
    • Research  (2,192)
    • Events  (38)
    • Multimedia  (28)
  • Faculty Publications  (1,297)
← Page 95 of 3,417 Results →
  • June 11, 2021
  • Article

Addressing Demographic Disparities in Clinical Trials

By: Kathy Giusti, Richard G. Hamermesh and Mark Krasnow
Disparities in health care are not just limited to the delivery of care. They also exist in the way that clinical trials are structured. Women, people of color, and the elderly often are not adequately represented. This article offers three strategies for addressing... View Details
Keywords: Health Testing and Trials; Demographics
Citation
Find at Harvard
Register to Read
Related
Giusti, Kathy, Richard G. Hamermesh, and Mark Krasnow. "Addressing Demographic Disparities in Clinical Trials." Harvard Business Review Digital Articles (June 11, 2021).
  • January 17, 2022
  • Article

Reducing Racial Disparities in Cancer Outcomes

By: Kathy Giusti and Richard G. Hamermesh
A disproportionate number of Black patients die from cancer in the United States. A key to addressing this problem is enrolling more Black patients in clinical trials. A strategy consisting of these three parts can help accomplish this goal: 1) centralize information... View Details
Keywords: Cancer Trials; Racial Disparity; Health Testing and Trials; Race; Strategy
Citation
Read Now
Related
Giusti, Kathy, and Richard G. Hamermesh. "Reducing Racial Disparities in Cancer Outcomes." Harvard Business Review (website) (January 17, 2022).
  • Article

Quantifying the Use of Connected Digital Products in Clinical Research

By: Caroline Marra, Jacqueline L. Chen, Andrea Coravos and Ariel D. Stern
Over recent years, the adoption of connected technologies has grown dramatically, with potential for improving health care delivery, research, and patient experience. Yet, little has been documented about the prevalence and use of connected digital products (e.g.,... View Details
Keywords: Connected Digital Products; Clinical Trials; Health Testing and Trials; Information Technology; Research
Citation
Read Now
Related
Marra, Caroline, Jacqueline L. Chen, Andrea Coravos, and Ariel D. Stern. "Quantifying the Use of Connected Digital Products in Clinical Research." Art. 50. npj Digital Medicine 3 (2020).
  • 15 Jun 2004
  • Conference Presentation

What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study

By: William B. Simpson, Frances J. Hayes, Andre B. Araujo and John B. McKinlay
Keywords: Measurement and Metrics; Health Testing and Trials; Age Characteristics; Gender Characteristics; Massachusetts
Citation
Related
Simpson, William B., Frances J. Hayes, Andre B. Araujo, and John B. McKinlay. "What is the Best Measure of Adiposity for Predicting Testosterone? Results from the Massachusetts Male Aging Study." Paper presented at the Enocrine Society Annual Meeting, New Orleans, LA, June 15, 2004.
  • 28 Jan 2016
  • News

Harvard Business School Launches Precision Trials Challenge

Keywords: Scientific Research and Development Services
  • January 2020
  • Article

The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System

By: Peter P. Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry and Mark J. Pirwitz
Background. A meta-analysis of trials in endovascular therapy suggested an increased mortality associated with treatment exposure to paclitaxel. Multiple publications and corrections of prior data were performed, and the United States Food and Drug Administration has... View Details
Keywords: Medical Devices; Health Testing and Trials; Analysis; Sales
Citation
Read Now
Related
Monteleone, Peter P., Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry, and Mark J. Pirwitz. "The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System." Journal of Invasive Cardiology 32, no. 1 (January 2020).
  • 14 Jun 2016
  • News

HBS Alumna Now Kraft Precision Medicine Accelerator’s Codirector

Keywords: Scientific Research and Development Services
  • 16 Apr 2019
  • Working Paper Summaries

Can Biometric Tracking Improve Healthcare Provision and Data Quality? Experimental Evidence from Tuberculosis Control in India

Keywords: by Thomas Bossuroy, Clara Delavallade, and Vincent Pons; Health; Medical Devices & Supplies
  • 07 Sep 2016
  • News

HBS Names 2016-2017 Blavatnik Fellows in Life Science Entrepreneurship

Keywords: Blavatnik; Scientific Research and Development Services
  • 05 Nov 2009
  • Research & Ideas

A Market for Human Cadavers in All but Name?

(Editor's Note: In a recent issue, Economic Sociology: The European Electronic Newsletter tackled the controversial issue of "commodification of the body." Harvard Business School professor Michel Anteby contributed the following essay that discusses issues... View Details
Keywords: by Michel Anteby; Health
  • 15 Jan 2021
  • News

To Overcome Vaccine Hesitancy, We Need a Better Patient Experience

  • 14 May 2020
  • News

Perspectives in Health: Everlywell, Diagnostics and COVID

  • 19 Apr 2016
  • News

LuminOva Makes Great Strides Tackling Infertility

Alexandra Dickson (MBA 2013) Alexandra Dickson (MBA 2013) LuminOva, a biotech startup in Boston that won the 2015 Bertarelli Prize, is making progress on its quest to develop a new technology that could increase in vitro fertilization success rates by monitoring the... View Details
Keywords: Blavatnik; Scientific Research and Development Services
  • 24 Apr 2014
  • News

Finding a cure for cancer became a personal mission

Thai Lee (MBA 1985), president and CEO of SHI International, talks about how a family crisis led her to funding cancer research. (Published April 2014) View Details
  • 2006
  • Chapter

BioRisk: interleukin-2 from laboratory to market in the United States and Germany

By: Arthur A. Daemmrich
Keywords: Product Development; Risk and Uncertainty; Health Testing and Trials; Pharmaceutical Industry; Biotechnology Industry; United States; Germany
Citation
Related
Daemmrich, Arthur A. "BioRisk: interleukin-2 from laboratory to market in the United States and Germany ." In The Risks of Medical Innovation: Risk Perception and Assessment in Historical Context, edited by Thomas Schlich and Ulrich Tröhler, 242–261. Routledge, 2006.
  • December 2014 (Revised August 2015)
  • Case

Improving Melanoma Screening: MELA Sciences

By: Regina E. Herzlinger, Kevin Schulman and Frédéric Dijols
MELA is a start-up medical device company looking to develop a novel technology to help physicians diagnose a deadly skin cancer, melanoma. The case reviews the FDA medical device development process, the development path pursued by MELA, and the regulatory and... View Details
Keywords: Healthcare Industry; Health Care; Health; Health Care and Treatment; Health Testing and Trials; Health Industry; United States
Citation
Educators
Related
Herzlinger, Regina E., Kevin Schulman, and Frédéric Dijols. "Improving Melanoma Screening: MELA Sciences." Harvard Business School Case 315-042, December 2014. (Revised August 2015.)
  • 28 Feb 2020
  • News

Filling the White Space

At Able Partners, Amanda Eilian (MBA 2006) and Lisa Blau (MBA 2003) have focused primarily on women-led wellness companies, including businesses such as Goop, Moon Juice, and Daily Harvest. Now the New York–based investment firm has turned its attention to Compass... View Details
Keywords: venture capital; pharmaceutical research; innovative investing
  • 01 Jun 2018
  • News

Floor It

case study with the Multiple Myeloma Research Foundation, GNS Healthcare, the Moffitt Cancer Center’s ORIEN program, and biotech firm Foundation Medicine. Rethinking Drug Trials In an adaptive platform trial, different drugs are simultaneously View Details
Keywords: Julia Hanna; illustration by Mengxin Li
  • 13 Oct 2016
  • News

Adding Muscle to the Fight Against Disease

hundreds of millions of dollars, the ALS grant to Cytokinetics is significant because it facilitates the collection of plasma samples from test subjects over an extended period of time. The samples will be shared with academic... View Details
Keywords: Deborah Blagg
  • 25 Apr 2014
  • News

Bringing a new funding model to the life sciences industry

Andrew Farquharson (MBA 1999) wants to change the landscape for biomedical financing. The cofounder of VentureHealth, an online funding platform based in Silicon Valley, Farquharson leverages deals with investors who want access to biomedical startups. "If we can... View Details
  • ←
  • 95
  • 96
  • …
  • 170
  • 171
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.